The TSEC, ‘Duavive’, has been revealed…“Its strong point is safety”
The new menopausal symptom treatment uncovered its veil. Pfizer has launched the menopausal symptom treatment ‘Duavive’.
Duaviveattractedattention through the TSEC (tissue selective estrogen complex) combining ‘bazedoxifene (BZA)’ and ‘conjugated estrogen (CE)’.
Duavive, which acquired a sale a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
